Medicine Status
Rizatriptan 10 mg Oral Tablet (also know as Maxalt)
Pill Identifier
Medicine Status
About Medicine Status
Copyright © 2020 and Spring Launch Media LLC. All Rights Reserved.

All content on this website ("the Site") is the property of Spring Launch Media LLC. The collection and assembly of content on this Site are the exclusive property of Spring Launch Media LLC and are protected by copyright and other intellectual property laws. does not provide medical advice, diagnosis, or treatment, and urges you to consult with a qualified medical provider for diagnosis, treatment, and for answers to your medical questions. does not warrant or assume any legal liability or responsibility for the accuracy, completeness, or usefulness of any information disclosed. does not assume any responsibility for any aspect of medical care administered based on the contents provided on this Site. The contents of, such as text, images, graphics, or other material are solely for informational purposes. does not recommend or endorse any specific provider, opinions, procedures, or other information on the Site. Rely on any information provided by or displayed on this Site solely at your own risk. Consult a healthcare professional before taking any drug, choosing or changing any course of treatment.

Rizatriptan 10 mg Oral Tablet (also know as Maxalt)

Pill Finder Wizard
Overview Rizatriptan 10 mg Oral Tablet (also know as Maxalt) is a oval shaped, pinktablet that is approximately 12 mm in size. It has one score and can be broken into two pieces.

It is imprinted with "MAXALT", "MRK", and "267" and is supplied by Merck Sharp & Dohme Corp.
Drug Name Maxalt
Dosage Form Tablet
Imprint(s) MAXALT, MRK, 267
Pill Size 12 mm
DEA Schedule (Potential for Drug Abuse)
Drug Ingredients
Active Ingredient(s) Rizatriptan Benzoate
Inactive Ingredient(s) Lactose Monohydrate, Cellulose, Microcrystalline, Starch, Corn, Ferric Oxide Red, Magnesium Stearate
Drug Codes
RxNorm Concept Unique Identifier 213,322
National Drug Code 60267
Marketing Category NDA
Supplier Merck Sharp & Dohme Corp.
References The data for Rizatriptan 10 mg Oral Tablet (also know as Maxalt) was updated by the U.S National Library of Medicine on January 18, 2018.

  • U.S. National Library of Medicine. Accessed June 8, 2019.
  • Drug Scheduling. United States Drug Enforcement Administration. Accessed June 8, 2019.
  • Structured Product Labeling Resources. U.S. Food & Drug Administration. March 27, 2018. Accessed June 8, 2019.
  • HL7 Reference Information Model. HL7 Interational. Accessed June 8, 2019.